M. Dubar

676 total citations
16 papers, 536 citations indexed

About

M. Dubar is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, M. Dubar has authored 16 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in M. Dubar's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Diet, Metabolism, and Disease (3 papers) and Diet and metabolism studies (3 papers). M. Dubar is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Diet, Metabolism, and Disease (3 papers) and Diet and metabolism studies (3 papers). M. Dubar collaborates with scholars based in France, United States and Mexico. M. Dubar's co-authors include Fabrice Hurbin, Frank LaCreta, L. Bergougnan, Laurent Perrin, Dominick J. Angiolillo, Olivier Nicolas, C. Michael Gibson, Céline Ollier, Shuk Han Cheng and J. Meynadier and has published in prestigious journals such as Cancer, Pain and Annals of the New York Academy of Sciences.

In The Last Decade

M. Dubar

16 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Dubar France	10	318	126	121	98	75	16	536
Maria Antonietta Satta Italy	6	316 1.0×	76 0.6×	104 0.9×	355 3.6×	48 0.6×	6	631
C Lechi Italy	16	231 0.7×	109 0.9×	78 0.6×	140 1.4×	122 1.6×	45	657
JP Maffrand France	7	277 0.9×	33 0.3×	101 0.8×	65 0.7×	37 0.5×	9	396
Victor Skrinska United States	16	115 0.4×	66 0.5×	85 0.7×	97 1.0×	110 1.5×	32	547
N. Dowd Ireland	11	253 0.8×	41 0.3×	226 1.9×	125 1.3×	53 0.7×	22	747
E. Vallée France	7	285 0.9×	50 0.4×	117 1.0×	60 0.6×	52 0.7×	7	470
H.‐J. Mest Germany	12	152 0.5×	173 1.4×	141 1.2×	93 0.9×	138 1.8×	61	559
Christopher Doe United States	14	220 0.7×	72 0.6×	139 1.1×	113 1.2×	199 2.7×	21	579
B. Müller‐Beckmann United States	13	296 0.9×	69 0.5×	87 0.7×	64 0.7×	225 3.0×	27	684
Rosamaria Tommasoli Italy	8	165 0.5×	34 0.3×	75 0.6×	86 0.9×	51 0.7×	9	448

Countries citing papers authored by M. Dubar

Since Specialization

Citations

This map shows the geographic impact of M. Dubar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dubar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dubar more than expected).

Fields of papers citing papers by M. Dubar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dubar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dubar. The network helps show where M. Dubar may publish in the future.

Co-authorship network of co-authors of M. Dubar

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dubar. A scholar is included among the top collaborators of M. Dubar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dubar. M. Dubar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Florian, Peter, et al.. (2017). Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber. European Journal of Clinical Pharmacology. 73(8). 949–956. 12 indexed citations

Bédard, Philippe L., Michael A. Davies, Scott Kopetz, et al.. (2017). First‐in‐human trial of the PI3Kβ‐selective inhibitor SAR260301 in patients with advanced solid tumors. Cancer. 124(2). 315–324. 30 indexed citations

Wilkins, Justin, et al.. (2013). A drug and disease model for lixisenatide, a GLP‐1 receptor agonist in type 2 diabetes. The Journal of Clinical Pharmacology. 54(3). 267–278. 9 indexed citations

Simon, Tabassome, Deepak L. Bhatt, L. Bergougnan, et al.. (2011). Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects. Clinical Pharmacology & Therapeutics. 90(2). 287–295. 69 indexed citations

Sollier, Claire Bal dit, et al.. (2010). Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel. Thrombosis and Haemostasis. 104(9). 571–581. 33 indexed citations

Angiolillo, Dominick J., C. Michael Gibson, Shuk Han Cheng, et al.. (2010). Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies. Clinical Pharmacology & Therapeutics. 89(1). 65–74. 214 indexed citations

Osende, Julio, Daichi Shimbo, Valentı́n Fuster, M. Dubar, & Juan J. Badimón. (2004). Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist. Journal of Thrombosis and Haemostasis. 2(3). 492–498. 43 indexed citations

Gaussem, Pascale, et al.. (2002). Dose‐effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects. British Journal of Clinical Pharmacology. 53(2). 147–154. 3 indexed citations

Pénicaud, Luc, et al.. (1998). Rilmenidine normalizes fructose-induced insulin resistance and hypertension in rats.. PubMed. 16(3). S45–9. 37 indexed citations

10.

Boucher, Michel, et al.. (1996). Interactions of the cardiac chronotropic effects of rilmenidine with the autonomic nervous system in conscious dogs: comparison with clonidine. Journal of Autonomic Pharmacology. 16(1). 13–20. 2 indexed citations

11.

Dubar, M., et al.. (1996). [Effects of rilmenidine on rats made insulin resistant and hypertensive by a high fructose diet].. PubMed. 89(8). 1103–6. 2 indexed citations

12.

Dubar, M., et al.. (1995). I₁ Agents: A New Approach to the Treatment of Hypertension. Annals of the New York Academy of Sciences. 763(1). 642–658. 10 indexed citations

13.

Boucher, Michel, et al.. (1994). Cardiac electrophysiological effects of rilmenidine, a novel antihypertensive agent, in the conscious dog : Comparison with clonidine. Life Sciences. 54(22). PL381–PL387. 3 indexed citations

14.

Huguet, François, Anne‐Marie Brisac, M. Dubar, Pierre Ingrand, & Alain Piriou. (1993). Endothelin modulates dihydropyridine receptor decreased binding in hippocampal slices from normotensive and spontaneously hypertensive rats. International Journal of Developmental Neuroscience. 11(3). 295–301. 1 indexed citations

15.

Fournier, Bernard & M. Dubar. (1989). Relationship between neuroparsin-induced rectal fluid reabsorption and cyclic nucleotides in the migratory locust. Comparative Biochemistry and Physiology Part A Physiology. 94(2). 249–255. 10 indexed citations

16.

Meynadier, J., J. Chrubasik, M. Dubar, & Erich Wünsch. (1985). Intrathecal somatostatin in terminally ill patients. A report of two cases. Pain. 23(1). 9–12. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact